Subjective Experiences of Antipsychotic Treatment: A Comparison of First- and Second-generation Medications among Patients with Schizophrenia
Journal Title: International Neuropsychiatric Disease Journal - Year 2016, Vol 7, Issue 1
Abstract
Aims: The patient’s perspective of antipsychotic treatment has been a relatively neglected area of research. Whether subjective experiences of antipsychotic treatment are better among patients on second-generation antipsychotics (SGAs), than those on first-generation antipsychotics (FGAs) has also evoked some controversy. This study attempted a longitudinal comparison of attitudes toward treatment, subjective well-being and quality of life (QOL) between patients on SGAs and FGAs. Socio-demographic and clinical correlates of these subjective experiences were also examined. Methodology: Standardised ratings of insight, psychopathology, side-effects, attitudes, subjective well-being and QOL were carried out among 40 patients with schizophrenia on SGAs and 30 on FGAs, over a 6-month period. Results: Both groups were similar in the first 3-month period, apart from the slightly greater severity of illness in the FGA group. Differences in symptom-severity and side-effects emerged between the groups over the course of follow-up. Moreover, as the study progressed, differences also became apparent in subjective experiences; patients on SGAs had significantly better attitudes, subjective well-being and QOL than those on FGAs. However, differences between individual SGAs (olanzapine and risperidone) on these indices were minimal. The three indices of subjective experience were highly correlated with each other. Older age, being employed, greater insight, lower symptom-severity and the absence of side-effects demonstrated significant positive associations with different aspects of subjective experiences. Conclusions: Patients on SGAs had a more favourable profile of subjective experiences with treatment than those on FGAs. These differences seemed to be determined mainly by differences in symptom-severity and side-effects.
Authors and Affiliations
Subho Chakrabarti, Nisha Warikoo, Sandeep Grover
Keywords
Related Articles
- EP ID EP241847
- DOI 10.9734/INDJ/2016/24769
- Views 131
- Downloads 0
Mental Health Issues in Multiple Sclerosis Patients and Healthy Controls and Their Association with Disease Related Factors
Purpose: To investigate the mental health problems of multiple sclerosis (MS) patients, and the relationship between mental health, MS variables and disability status. Methods: The sample consisted of 80 participants, 4...
Training Contributions of Executive Functions in Perception of Quality of Life in Elderly
Aims: Verify the presence or lack of improvement in quality of life perception, comparing the results of the evaluation from both elderly groups that participated on the executive functions training research. Study Desig...
Theory of Mind Development is Impaired in 4-Year-Old Children with Prenatal Exposure to Maternal Tobacco Smoking
Aims: Theory of Mind (ToM) is an important component of social cognition. Deficits in ToM are found in various neurodevelopmental disorders and social and environmental factors have been found to influence ToM developmen...
Do Psychiatry and Family Medicine Residents Differ with Regard to Attitudes towards Treating Substance Use Patients
Background and Objective: Substance use disorders are a major health issue affecting many who present for treatment for psychiatric and medical problems. Substance use is associated with employment problems, relational d...
Interleukin-2 Treatment Induces an Acquired Behavioral Response Pattern (Repetitive Stereotyped Movements) Mediated by Dopamine D1 and D2 Receptors
Interleukin (IL)-2 is implicated in the etiology of psychiatric disorders (e.g., schizophrenia, psychosis) involving an increased expression of repetitive stereotyped movements. However, little is known about the underly...